GeoVax reports significant advance in HIV vaccine development
Elicitation of a Key Precursor for Broadly Neutralizing Antibody for the HIV CD4 Binding Site
                                                    
                                                    
                                                Elicitation of a Key Precursor for Broadly Neutralizing Antibody for the HIV CD4 Binding Site